4Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death[M]//Braunwald E, Zipes DP, Libby P, eds. Heart Disease:A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia:WB Saunders, 2001:890-931.
5Domanski MJ, Exner DV, Borkowf CB, et al. Effect of angiotensin converting enzyme inhibition on sudden death in patients following acute myocardial infarction: a meta - analysis of randomized clinical trials[J]. J Am Coll Cardial, 1999, 33:598-604.
6Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbitity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial[J]. N Engl J Med, 1991,324:781-788.
7The Cardiac Arrhythmic Suppression Trial Ⅱ Investigators. Effect of the antiarrhythmic drug moricizine on survival after myocardial infarction[J]. N Engl J Med, 1992, 327:227-233.
8Siebels J, Kuck KH, and the CASH Investigators. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors( the Cardiac Arrest Study of Hamburg) [J]. Am Heart J, 1994, 127 : 1139-1144.
9Doherty JU, Fuchs S, Tecce MA. Ventricular arrhythmias. Preventing sudden death with drugs and ICD devices[J]. Geriatrics,2000, 55(8):26-28;31-32;35-36.
10Julian DG, Camm AJ, Frangin G, et al. Randomozed trial of amiodarone on mortality in patients with left- ventricular dysfunction after recent myocardial infarction. EMIAT. European Myocardial Infarct Amiodarone Trial Inveatigators [ J ]. Lancet, 1997,349 : 667-674.
